Table 4.

Dose-response in imputed primary outcome at posttreatment and along the follow-up.

Interventions			Pretreatment to posttreatment				Pretreatment to posttreatment				Pretreatment to posttreatment
			βa (95% CI)		P value		β (95% CI)		P value		β (95% CI)		P value
HLPb
	CACEc analysisd	–3.32 (4.43 to –2.21)		.004 e		–0.51 (2.03 to 1.02)		.74		–1.03 (2.61 to 0.56)		.52
	Effect per session	–0.28 (0.34 to –0.21)		.001		–0.17 (0.25 to –0.09)		.03		–0.06 (0.13 to 0.02)		.45
MPf
	CACE analysis	0.93 (0.71 to 2.57)		.57		1.01 (0.72 to 2.74)		.56		1.13 (0.5 to 2.76)		.49
	Effect per session	0.26 (0.22 to 0.74)		.59		–0.17 (0.25 to –0.09)		.03		–0.06 (0.13 to 0.02)		.45
PAPPg
	CACE analysis	0.24 (1.30 to 1.78)		.88		0.96 (0.66 to 2.57)		.56		0.30 (1.24 to 1.84)		.85
	Effect per session	–0.28 (0.34 to –0.21)		.001		–0.17 (0.25 to –0.09)		.03		–0.06 (0.13 to 0.02)		.45
All
	CACE analysis	–2.11 (2.86 to –1.36)		.006		–0.49 (1.37 to 0.4)		.58		–0.22 (1.04 to 0.6)		.79
	Effect per session	–0.28 (0.34 to –0.21)		.001		–0.17 (0.25 to –0.09)		.03		–0.06 (0.13 to 0.02)		.45

^aβ: regression coefficients.

^bHLP: healthy lifestyle program.

^cCACE: Complier Average Causal Effect.

^dCompliance as attendance >4 modules.

^eStatistically significant values (P<.05) are shown in italics.

^fMP: mindfulness program.

^gPAPP: positive affect promotion program..